| resumeang: Social phobia (SPH) was neglected by psychopharmacologically oriented researchers until the mid-1980s. Researchers in the field have benefitted from the experience with other anxiety and other affective disorders and from interdisciplinary collaborative arrangements between psychopharmacological and cognitive behavioral investigators. Due to these benefits, in the past few years the field of treatment research in SPH has advanced and investigative models have been created that are being adapted for other disorders. The early clinical trials with psychopharmacologic treatment for SPH are described, and a collaborative treatment study (Liebowitz and Heimberg) is outlined. Preliminary results from the latter study suggest positive results for both phenelzine treatment and cognitive behavioral group therapy. (PsycINFO Database Record (c) 2000 APA, all rights reserved). |
